| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gated channel activity | 1.39e-05 | 334 | 66 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.69e-05 | 343 | 66 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.92e-05 | 459 | 66 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | 1-acylglycerol-3-phosphate O-acyltransferase activity | 4.40e-05 | 21 | 66 | 3 | GO:0003841 | |
| GeneOntologyMolecularFunction | channel activity | 5.47e-05 | 525 | 66 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.56e-05 | 526 | 66 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.43e-05 | 4 | 66 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | transporter activity | ABCG4 KCND3 PIEZO1 SCN8A TMC8 TMEM63C SLC15A5 ATP9B HTR3B STRA6 SLC36A2 RYR1 CHRNB3 RYR2 | 6.61e-05 | 1289 | 66 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | lysophosphatidic acid acyltransferase activity | 6.64e-05 | 24 | 66 | 3 | GO:0042171 | |
| GeneOntologyMolecularFunction | lysophospholipid acyltransferase activity | 6.64e-05 | 24 | 66 | 3 | GO:0071617 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.00e-04 | 140 | 66 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCG4 KCND3 PIEZO1 SCN8A TMC8 TMEM63C SLC15A5 HTR3B STRA6 SLC36A2 RYR1 CHRNB3 RYR2 | 1.09e-04 | 1180 | 66 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 1.60e-04 | 32 | 66 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.60e-04 | 6 | 66 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCND3 PIEZO1 SCN8A TMC8 TMEM63C HTR3B SLC36A2 RYR1 CHRNB3 RYR2 | 2.59e-04 | 793 | 66 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.21e-04 | 664 | 66 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.76e-04 | 288 | 66 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.44e-04 | 193 | 66 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.87e-04 | 197 | 66 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | retinoid binding | 5.36e-04 | 48 | 66 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 5.70e-04 | 49 | 66 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.65e-04 | 211 | 66 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 9.82e-04 | 59 | 66 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VIPR1 CXCR3 OR2AK2 KISS1R GPR158 IL17RE TMEM63C OR1K1 FCRLA HTR3B OR4K15 CHRNB3 | 1.44e-03 | 1353 | 66 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.59e-03 | 18 | 66 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.59e-03 | 18 | 66 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.65e-03 | 153 | 66 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.85e-03 | 28 | 66 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.44e-03 | 100 | 66 | 3 | GO:0030594 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.31e-05 | 52 | 66 | 4 | GO:0008210 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1 | 1.03e-07 | 1293 | 68 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1 | 1.10e-07 | 1299 | 68 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMX2 ESYT2 PIGA AGPAT5 RETREG2 SBF1 MBOAT7 WFS1 PIEZO1 TMC8 UGT2B15 UGT2B17 TMEM39A GPAT4 SLC36A2 RYR1 RYR2 PROS1 | 1.52e-07 | 1327 | 68 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 4.61e-04 | 10 | 68 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | organelle membrane contact site | 8.50e-04 | 57 | 68 | 3 | GO:0044232 | |
| GeneOntologyCellularComponent | cation channel complex | 1.01e-03 | 235 | 68 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.43e-03 | 378 | 68 | 6 | GO:0034702 | |
| Domain | Ryanrecept_TM4-6 | 3.68e-05 | 3 | 66 | 2 | IPR009460 | |
| Domain | RyR | 3.68e-05 | 3 | 66 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 3.68e-05 | 3 | 66 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 3.68e-05 | 3 | 66 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.68e-05 | 3 | 66 | 2 | IPR013333 | |
| Domain | RIH_assoc | 1.83e-04 | 6 | 66 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.83e-04 | 6 | 66 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.83e-04 | 6 | 66 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.83e-04 | 6 | 66 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.83e-04 | 6 | 66 | 2 | IPR015925 | |
| Domain | - | 1.83e-04 | 6 | 66 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.83e-04 | 6 | 66 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.83e-04 | 6 | 66 | 2 | PF08709 | |
| Domain | MIR | 5.43e-04 | 10 | 66 | 2 | PS50919 | |
| Domain | MIR | 5.43e-04 | 10 | 66 | 2 | PF02815 | |
| Domain | MIR | 5.43e-04 | 10 | 66 | 2 | SM00472 | |
| Domain | MIR_motif | 5.43e-04 | 10 | 66 | 2 | IPR016093 | |
| Domain | Ion_trans_dom | 7.09e-04 | 114 | 66 | 4 | IPR005821 | |
| Domain | Ion_trans | 7.09e-04 | 114 | 66 | 4 | PF00520 | |
| Domain | Acyltransferase | 1.43e-03 | 16 | 66 | 2 | PF01553 | |
| Domain | PlsC | 1.62e-03 | 17 | 66 | 2 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 1.62e-03 | 17 | 66 | 2 | IPR002123 | |
| Domain | IQ | 2.03e-03 | 71 | 66 | 3 | PF00612 | |
| Domain | UDPGT | 2.47e-03 | 21 | 66 | 2 | PF00201 | |
| Domain | UDPGT | 2.47e-03 | 21 | 66 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 2.47e-03 | 21 | 66 | 2 | IPR002213 | |
| Domain | IQ | 2.95e-03 | 81 | 66 | 3 | SM00015 | |
| Domain | - | 2.97e-03 | 23 | 66 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.97e-03 | 23 | 66 | 2 | IPR027361 | |
| Domain | IQ_motif_EF-hand-BS | 3.98e-03 | 90 | 66 | 3 | IPR000048 | |
| Domain | HECT | 4.08e-03 | 27 | 66 | 2 | PF00632 | |
| Domain | HECTc | 4.08e-03 | 27 | 66 | 2 | SM00119 | |
| Domain | HECT_dom | 4.08e-03 | 27 | 66 | 2 | IPR000569 | |
| Domain | HECT | 4.08e-03 | 27 | 66 | 2 | PS50237 | |
| Domain | IQ | 4.36e-03 | 93 | 66 | 3 | PS50096 | |
| Domain | EF-hand_8 | 6.41e-03 | 34 | 66 | 2 | PF13833 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32660355 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 3.77e-06 | 2 | 68 | 2 | 14722100 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 1909870 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 3.77e-06 | 2 | 68 | 2 | 26009179 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24121496 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32899693 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 3.77e-06 | 2 | 68 | 2 | 3117546 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24267955 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30542613 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22170718 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21933672 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 3.77e-06 | 2 | 68 | 2 | 11673493 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11673462 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 3.77e-06 | 2 | 68 | 2 | 3105095 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17848572 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 3.77e-06 | 2 | 68 | 2 | 25370123 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27496708 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 3.77e-06 | 2 | 68 | 2 | 15033925 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28228532 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 3.77e-06 | 2 | 68 | 2 | 18618700 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15666817 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17698910 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SBF1 IL17RE KLHL21 PIEZO1 SCN8A TSC2 UBE3C ARHGAP35 SNAPC4 GPAT4 RYR1 | 9.26e-06 | 1105 | 68 | 11 | 35748872 |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18403125 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19572376 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 34767155 | ||
| Pubmed | Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model. | 1.13e-05 | 3 | 68 | 2 | 26880751 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18434746 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 1.13e-05 | 3 | 68 | 2 | 26163549 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 20736324 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.13e-05 | 3 | 68 | 2 | 9204703 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7876312 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 21881589 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24123915 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 26385605 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 28882566 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.13e-05 | 3 | 68 | 2 | 12213830 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23278119 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 9242641 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22948152 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 1.13e-05 | 3 | 68 | 2 | 23454728 | |
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.13e-05 | 3 | 68 | 2 | 10788707 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17988216 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.13e-05 | 3 | 68 | 2 | 7621815 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18643873 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11159936 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23223495 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 1.13e-05 | 3 | 68 | 2 | 9986730 | |
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 1.13e-05 | 3 | 68 | 2 | 18302198 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30689982 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.13e-05 | 3 | 68 | 2 | 10473538 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.13e-05 | 3 | 68 | 2 | 4600883 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7635066 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 18206662 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 22504960 | ||
| Pubmed | Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release. | 2.25e-05 | 4 | 68 | 2 | 23992453 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.25e-05 | 4 | 68 | 2 | 23413940 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9384575 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9607712 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 27226555 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 18281521 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 26176234 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 19120137 | ||
| Pubmed | FKBP binding characteristics of cardiac microsomes from diverse vertebrates. | 2.25e-05 | 4 | 68 | 2 | 11237759 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 23482488 | ||
| Pubmed | 2.74e-05 | 300 | 68 | 6 | 19086053 | ||
| Pubmed | Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. | 3.75e-05 | 5 | 68 | 2 | 22939628 | |
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 3.75e-05 | 5 | 68 | 2 | 9124414 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.75e-05 | 5 | 68 | 2 | 19011160 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 5.47e-05 | 499 | 68 | 7 | 22810586 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.62e-05 | 6 | 68 | 2 | 26025922 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 5.62e-05 | 6 | 68 | 2 | 14592808 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.62e-05 | 6 | 68 | 2 | 25966694 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 19009018 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 21365123 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.62e-05 | 6 | 68 | 2 | 16844763 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 11860456 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 26074487 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 20962236 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 32093886 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.05e-04 | 8 | 68 | 2 | 19033399 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 22579593 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 11784029 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 18719240 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 20142249 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 18434328 | ||
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 1.94e-04 | 57 | 68 | 3 | 23788249 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.45e-04 | 12 | 68 | 2 | 20308471 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 19095005 | ||
| Pubmed | Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development. | 3.21e-04 | 166 | 68 | 4 | 19906978 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 3.32e-04 | 1124 | 68 | 9 | 21900206 | |
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 3.38e-04 | 14 | 68 | 2 | 28724790 | |
| Interaction | OPALIN interactions | 2.78e-07 | 209 | 63 | 8 | int:OPALIN | |
| Interaction | STARD3NL interactions | 2.10e-05 | 52 | 63 | 4 | int:STARD3NL | |
| Cytoband | 4q13 | 2.31e-04 | 15 | 69 | 2 | 4q13 | |
| Cytoband | 7q36.3 | 6.01e-04 | 24 | 69 | 2 | 7q36.3 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.34e-05 | 3 | 51 | 2 | 287 | |
| GeneFamily | 1-acylglycerol-3-phosphate O-acyltransferases | 4.22e-04 | 11 | 51 | 2 | 46 | |
| Drug | Ryanodine | 5.50e-06 | 12 | 68 | 3 | ctd:D012433 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A | 1.74e-05 | 182 | 68 | 6 | 6663_UP | |
| Drug | Androstane-3,17-diol | 2.01e-05 | 18 | 68 | 3 | ctd:D015113 | |
| Drug | 2-hydroxycarbazole | 2.63e-05 | 3 | 68 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 2.63e-05 | 3 | 68 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.63e-05 | 3 | 68 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.63e-05 | 3 | 68 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 2.63e-05 | 3 | 68 | 2 | CID000127713 | |
| Drug | aminodantrolene | 2.63e-05 | 3 | 68 | 2 | CID009570289 | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 2.72e-05 | 197 | 68 | 6 | 601_DN | |
| Drug | 2,2',3,5',6-pentachlorobiphenyl | 2.80e-05 | 20 | 68 | 3 | ctd:C032904 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A | 2.97e-05 | 200 | 68 | 6 | 6333_UP | |
| Drug | PCB74 | 5.25e-05 | 4 | 68 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 5.25e-05 | 4 | 68 | 2 | CID006444275 | |
| Drug | SC 38249 | 5.25e-05 | 4 | 68 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 5.25e-05 | 4 | 68 | 2 | CID000035682 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.39e-05 | 3 | 64 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.39e-05 | 3 | 64 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | cholic acid glucuronide measurement | 1.39e-05 | 3 | 64 | 2 | EFO_0800574 | |
| Disease | X-25937 measurement | 2.77e-05 | 4 | 64 | 2 | EFO_0800937 | |
| Disease | X-24574 measurement | 9.66e-05 | 7 | 64 | 2 | EFO_0800897 | |
| Disease | deoxycholic acid glucuronide measurement | 1.29e-04 | 8 | 64 | 2 | EFO_0800575 | |
| Disease | obsolete_red blood cell distribution width | GPR158 HECW2 PIEZO1 TMC8 UGT2B15 SLC15A5 PDS5A AK9 TIPRL NR1I3 CHRNB3 | 1.38e-04 | 1347 | 64 | 11 | EFO_0005192 |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.06e-04 | 10 | 64 | 2 | EFO_0022090 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.52e-04 | 11 | 64 | 2 | EFO_0801531 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.01e-04 | 12 | 64 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 3.56e-04 | 13 | 64 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 3.56e-04 | 13 | 64 | 2 | EFO_0800799 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.14e-04 | 14 | 64 | 2 | EFO_0800283 | |
| Disease | depressive disorder (is_implicated_in) | 6.17e-04 | 17 | 64 | 2 | DOID:1596 (is_implicated_in) | |
| Disease | sweet liking measurement | 6.93e-04 | 18 | 64 | 2 | EFO_0010156 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 6.93e-04 | 18 | 64 | 2 | EFO_0800288 | |
| Disease | etiocholanolone glucuronide measurement | 7.73e-04 | 19 | 64 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 8.58e-04 | 20 | 64 | 2 | EFO_0800317 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.62e-04 | 195 | 64 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | X-24947 measurement | 1.04e-03 | 22 | 64 | 2 | EFO_0800910 | |
| Disease | lymphocyte count, response to vaccine | 1.04e-03 | 22 | 64 | 2 | EFO_0004587, EFO_0004645 | |
| Disease | West Syndrome | 1.24e-03 | 24 | 64 | 2 | C0037769 | |
| Disease | metabolite measurement | 1.34e-03 | 560 | 64 | 6 | EFO_0004725 | |
| Disease | epiandrosterone sulfate measurement | 1.35e-03 | 25 | 64 | 2 | EFO_0021120 | |
| Disease | obsessive-compulsive symptom measurement | 2.07e-03 | 31 | 64 | 2 | EFO_0007802 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDRAFLPALYSLLFL | 51 | P49682 | |
| LARSFALLLPVYALG | 116 | A0FGR8 | |
| SFVLRRLPLFYTLFL | 226 | Q05901 | |
| LVLGIFFLALRLLAY | 621 | Q9H172 | |
| LVLLSRFDRLLFQSY | 406 | O95264 | |
| YFLGFLLLAARLPLD | 6 | Q14956 | |
| LFEYRARRFLSLPST | 611 | O94983 | |
| RARLGLYIFARVSLF | 1296 | O60306 | |
| LQRFYHRLLRPLSLF | 11 | Q9NVE4 | |
| PRRSLLAALFFFSLS | 11 | O43286 | |
| AAFRGLSRLTILYLF | 221 | Q86UN3 | |
| YLPLALHLASEFFLR | 66 | Q29RF7 | |
| LLRIPAFSRDLYLLL | 166 | Q8TE59 | |
| RRPLFRSCFILLPYL | 401 | Q7Z3E1 | |
| SAFLELFILRLAYRS | 441 | P22736 | |
| AFFTRPFYKALLRIL | 1326 | Q9P2P5 | |
| RPRDRFLYAKLLGLL | 306 | Q14994 | |
| ILLLPFLAILASYAR | 221 | Q8NG84 | |
| YLLRLFAAPSRYRFI | 241 | Q9UK17 | |
| ILYFEPSTFRCILLR | 471 | Q5T848 | |
| RFLLLFSYIIPISLR | 411 | O43861 | |
| RPLLLLAYFSRLCAK | 586 | Q8NFR9 | |
| LLRLGSLFCYSTRLF | 561 | Q9P1W3 | |
| RELQPFLFLTFSLLY | 21 | Q8NH41 | |
| PSRALERAFALYNLL | 196 | Q969F8 | |
| SYLLFFRALSLLGLP | 81 | Q96N66 | |
| CRGLLALLFPLRYSF | 251 | O95248 | |
| RPLFVLFLLLYVASL | 26 | Q8NGR3 | |
| LEAVRLPFVRRFYLL | 221 | Q9UJP4 | |
| RYCFLLPLRIALAFT | 171 | Q86UL3 | |
| LPLQRSAARLLFSFY | 196 | Q7L513 | |
| TLRYFTTERFLPLLR | 251 | P14061 | |
| RLLLYVRASPLFYES | 91 | Q9NZ38 | |
| ASRALRLAPFVYLLL | 11 | Q14CZ8 | |
| GFLFAIFLILLLVYR | 156 | P34741 | |
| FLTLLPLFIFQLLYR | 306 | A6NIM6 | |
| LSRNFYTLRFLALFL | 4556 | P21817 | |
| TLARDLYAFYPLLIR | 3361 | Q92736 | |
| FPFLSIRRSALLYIA | 1826 | Q5TCS8 | |
| LSLRYDLTVPFARYL | 126 | P49590 | |
| LRPFFLLSVSLLAYF | 101 | Q8NC44 | |
| FGLAALYAPVLLLRA | 91 | Q587I9 | |
| LYAPVLLLRARKFAL | 96 | Q587I9 | |
| SRLYMLSFLPFLVLL | 201 | Q495M3 | |
| ILLFLAFLLLFLYRR | 61 | A0A1B0GU29 | |
| EFLLSLRYFRIFIAL | 46 | Q9BQ49 | |
| LYLKFRLPEISRFSA | 311 | P07225 | |
| RRKLYLAALPLAFEA | 336 | Q9NRY4 | |
| NRRVLYAATFLLFPL | 506 | Q9BX79 | |
| LCYLLLPATRLFRAL | 6 | Q9UNK9 | |
| LFHSLPLLRYIFVRE | 106 | P37287 | |
| YLLSALLSAAFLLVR | 26 | Q9Y320 | |
| YSRLARSTLLLIPLF | 336 | P32241 | |
| IRSYFTFLRFLLLLN | 106 | Q8IU68 | |
| LACLLFLLAFLSYNR | 171 | Q8IUR5 | |
| ALPRRALAQYLLFLR | 16 | Q9NR77 | |
| PSSFFLLLRFFLRID | 176 | O75663 | |
| YFLFHRPLRLLNLLI | 411 | Q9NV64 | |
| PCYLILTLLRFSFDL | 801 | Q9P2H5 | |
| LLLYFLASPSLRTRF | 1646 | Q6ZS81 | |
| ALYILSPFNLIRRIA | 111 | Q9UQD0 | |
| YLLLRARFLAAFTLP | 1361 | Q5SXM2 | |
| RFSGLSLVYLLFLLL | 26 | Q92508 | |
| LAELFNIPFLYSLRF | 161 | P54855 | |
| RLLSAFLPARFYQAL | 36 | Q9NUQ2 | |
| LAELLNIPFLYSLRF | 161 | O75795 | |
| FLSTLARLPHLYRNF | 846 | P49815 | |
| PKVRLLYSLAFNARF | 441 | Q15386 | |
| VYSPLALRRLTAFLE | 181 | Q86SH2 | |
| LLRASIGYFLFLFAL | 556 | O76024 |